About this Research Topic

Abstract Submission Deadline 22 August 2022
Manuscript Submission Deadline 20 January 2023

Erythropoiesis is a highly regulated, multistep process in which hematopoietic stem cells commit to erythroid progenitors and then differentiate into mature enucleated red blood cells (RBCs). Erythroid disorders, in which abnormal erythrocyte maturation and/or morphology is associated with ineffective erythropoiesis, can result from direct impairment of medullary erythropoiesis (e.g., thalassemia syndromes), inherited bone marrow failure (e.g., Myelodysplastic Syndrome), red cell overproduction (e.g., Polycythemia Vera), or existing blood cell destruction (e.g., Sickle Cell Anemia). It can also be caused by immune-mediated RBC destruction or certain genetic diseases that predispose to abnormal RBC production or turnover. New therapeutic modalities for treating red cell disorders have emerged as a result of a better understanding of the disease pathophysiology and underlying molecular mechanisms, such as induction of fetal hemoglobin and interference with aberrant signaling pathways.

The goal of this Research Topic is to accelerate the publication of studies that contribute to our understanding of the cellular and molecular basis of erythropoiesis, as well as its clinical application to erythroid disorders. In addition, this Research Topic will cover all aspects of erythroid differentiation, from basic laboratory research to translational and clinical investigations, including erythrocyte hemostatic mechanisms, disorders, and hematologic oncology.

Original Research articles, Reviews and Mini-reviews are all welcome. All researchers working on this topic are cordially invited to submit their manuscripts.

This Research Topic may cover, but is not limited to, the following subtopics:
• Fine-tuning of erythroid differentiation to identify the potential drug targets for erythroid disorders;
• Pathology and disease biology of Myelodysplastic Syndrome and Myeloproliferative Neoplasms with dyserythropoiesis;
• Molecular diagnostics and therapeutics of erythroid disorders, including Anaemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasms;
• Pathophysiology of Anaemia in cancer.

Keywords: erythropoiesis, anaemia, myelodysplastic syndrome, myeloprolierative neoplasms, red blood cell, erythroid disorder


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Erythropoiesis is a highly regulated, multistep process in which hematopoietic stem cells commit to erythroid progenitors and then differentiate into mature enucleated red blood cells (RBCs). Erythroid disorders, in which abnormal erythrocyte maturation and/or morphology is associated with ineffective erythropoiesis, can result from direct impairment of medullary erythropoiesis (e.g., thalassemia syndromes), inherited bone marrow failure (e.g., Myelodysplastic Syndrome), red cell overproduction (e.g., Polycythemia Vera), or existing blood cell destruction (e.g., Sickle Cell Anemia). It can also be caused by immune-mediated RBC destruction or certain genetic diseases that predispose to abnormal RBC production or turnover. New therapeutic modalities for treating red cell disorders have emerged as a result of a better understanding of the disease pathophysiology and underlying molecular mechanisms, such as induction of fetal hemoglobin and interference with aberrant signaling pathways.

The goal of this Research Topic is to accelerate the publication of studies that contribute to our understanding of the cellular and molecular basis of erythropoiesis, as well as its clinical application to erythroid disorders. In addition, this Research Topic will cover all aspects of erythroid differentiation, from basic laboratory research to translational and clinical investigations, including erythrocyte hemostatic mechanisms, disorders, and hematologic oncology.

Original Research articles, Reviews and Mini-reviews are all welcome. All researchers working on this topic are cordially invited to submit their manuscripts.

This Research Topic may cover, but is not limited to, the following subtopics:
• Fine-tuning of erythroid differentiation to identify the potential drug targets for erythroid disorders;
• Pathology and disease biology of Myelodysplastic Syndrome and Myeloproliferative Neoplasms with dyserythropoiesis;
• Molecular diagnostics and therapeutics of erythroid disorders, including Anaemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasms;
• Pathophysiology of Anaemia in cancer.

Keywords: erythropoiesis, anaemia, myelodysplastic syndrome, myeloprolierative neoplasms, red blood cell, erythroid disorder


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic Editors

Loading..

Topic Coordinators

Loading..

articles

Sort by:

Loading..

authors

Loading..

views

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Share on

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.